Soluble CD30 and ELISA-detected human leukocyte antigen antibodies for the prediction of acute rejection in pediatric renal transplant recipients

Transplant International

Volumn 26, Issue 3, 2013, Pages 331-338

  Billing, Heiko ^a   Sander, Anja ^b   Süsal, Caner ^b   Ovens, Jörg ^b   Feneberg, Reinhard ^a   Höcker, Britta ^a   Vondrak, Karel ^c   Grenda, Ryszard ^d   Friman, Stybjorn ^e   Milford, David V ^f   Lucan, Mihai ^g   Opelz, Gerhard ^b   Tönshoff, Burkhard ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^d CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^f BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^g Clinical Institute of Urology   (Romania)

Author keywords

biopsy proven acute rejection; human leukocyte antigen antibodies; pediatric renal transplantation; soluble CD30; steroid free immunosuppression

Indexed keywords

CD30 ANTIGEN; CORTICOSTEROID; DACLIZUMAB; HLA ANTIGEN; HUMAN LEUKOCYTE ANTIGEN ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROTEIN ANTIBODY; SOLUBLE CD30 ANTIGEN; TACROLIMUS; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ANTIGEN DETECTION; ARTICLE; B LYMPHOCYTE ACTIVATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPLORATORY RESEARCH; FEMALE; GRAFT RECIPIENT; HUMAN; IMMUNOREACTIVITY; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; MULTICENTER STUDY; OPEN STUDY; OPTICAL DENSITY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY;

AGE FACTORS; ANTIGENS, CD30; BIOLOGICAL MARKERS; CHILD; CONFIDENCE INTERVALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HLA ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LOGISTIC MODELS; MALE; PEDIATRICS; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES; ROC CURVE; SOLUBILITY; SURVIVAL ANALYSIS; TIME FACTORS; TRANSPLANTATION IMMUNOLOGY; TREATMENT OUTCOME;

EID: 84874116026     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/tri.12049     Document Type: Article

References (26)

1. Wiebe C, Gibson IW, Blydt-Hansen TD, et al,. Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant. Am J Transplant 2012; 12: 1157.
2. Verghese PS, Smith JM, McDonald RA, Schwartz SM, Nelson KA, Warner PR,. Impaired graft survival in pediatric renal transplant recipients with donor-specific antibodies detected by solid-phase assays. Pediatr Transplant 2010; 14: 730.
3. Wieland E, Olbricht CJ, Süsal C, et al,. Biomarkers as a tool for management of immunosuppression in transplant patients. Ther Drug Monit 2010; 32: 560.
4. Durkop H, Latza U, Hummel M, Eitelbach F, Seed B, Stein H,. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell 1992; 68: 421.
5. Süsal C, Opelz G,. Posttransplant sCD30 as a biomarker to predict kidney graft outcome. Clin Chim Acta 2012; 8: 413.
6. Pelzl S, Opelz G, Daniel V, Wiesel M, Süsal C,. Evaluation of posttransplantation soluble CD30 for diagnosis of acute renal allograft rejection. Transplantation 2003; 75: 421.
7. Süsal C, Döhler B, Sadeghi M, et al,. Post transplant sCD30 as a biomarker to predict kidney graft outcome. Transplantation 2011; 9: 1364.
8. Härtel C, Adam N, Strunk T, Temmig P, Müller-Steinhardt M, Schultz C,. Cytokine responses correlate differentially with age in infancy and early childhood. Clin Exp Immunol 2005; 142: 446.
9. Grenda R, Watson A, Trompeter R, et al,. A randomized trial to assess the impact of early steroid withdrawal on growth in pediatric renal transplantation: the TWIST study. Am J Transplant 2010; 10: 828.
10. Süsal C, Döhler B, Ruhenstroth A, et al,. Association of kidney graft loss with posttransplant presence of strong HLA antibodies detected by Luminex single antigen testing. 24th International Congress of The Transplantation Society, 15-19 July, 2012; Abstract No. MON.CO16.01.
11. Schwartz GJ, Munoz A, Schneider MF, et al,. New equations to estimate GFR in children with CKD. J Am Soc Nephrol 2009; 20: 629.
12. Armstrong V, Schuetz E, Qingling Z, et al,. Modified pentamer formation assay for measurement of tacrolimus and its active metabolites: comparison with liquid chromatography-tandem mass spectrometry and microparticle enzyme-linked immunoassay (MEIA-II). Clin Chem 1998; 44: 2516.
13. Gonen M,. Analyzing Receiver Operating Characteristic Curves Using SAS. SAS Institute Inc., Cary, NC, 2007; 538.
14. Racusen LC, Solez K, Colvin RB, et al,. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713.
15. Solez K, Colvin RB, Racusen LC, et al,. Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 2007; 7: 518.
16. Spiridon C, Nikaein A, Lerman M, Hunt J, Dickerman R, Mack M,. CD30, a marker to detect the highrisk kidney transplant recipients. Clin Transplant 2008; 22: 765.
17. Slavcev A, Lacha J, Honsova E, et al,. Soluble CD30 and HLA antibodies as potential risk factors for kidney transplant rejection. Transpl Immunol 2005; 14: 117.
18. Matinlauri IH, Kyllönen LE, Salmela KT, Helin H, Pelzl S, Süsal C,. Serum sCD30 in monitoring of alloresponse in well HLA-matched cadaveric kidney transplantations. Transplantation 2005; 27: 1809.
19. Süsal C, Pelzl S, Döhler B, Opelz G., Identification of highly responsive kidney transplant recipients using pretransplant soluble CD30. J Am Soc Nephrol 2002; 13: 1650.
20. Süsal C, Opelz G,. Kidney graft failure and presensitization against HLA class I and class II antigens. Transplantation 2002; 73: 1269.
21. Lee PC, Terasaki PI, Takemoto SK, et al,. All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies. Transplantation 2002; 74: 1192.
22. Gould DS, Auchincloss H Jr,. Direct and indirect recognition: the role of MHC antigens in graft rejection. Immunol Today 1999; 20: 77.
23. Tambur AR, Gebel HM,. Alloantigen processing and presentation. J Heart Lung Transplant 1995; 14: 1031.
24. Tambur AR, Bray RA, Takemoto SK, et al,. Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection. Transplantation 2000; 15: 1055.
25. Sánchez-Fructuoso AI, Santiago JL, Pérez-Flores I,. Calvo Romero N, Valero R. De novo anti-HLA antibodies in renal allograft recipients: a cross-section study. Transplant Proc 2010; 42: 2874.
26. Rostaing L, Cantarovich D, Mourad G, et al,. Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation. Transplantation 2005; 15: 807.